Artificial Retinas Made on ISS Outperform Earth-Made Counterparts
Biotech company LambdaVision has successfully manufactured artificial retinas in microgravity aboard the International Space Station, with results showing superior quality and efficiency compared to Earth-based production.
LambdaVision has been utilizing the International Space Station (ISS) as a manufacturing hub for nearly a decade, developing an artificial retina composed of hundreds of alternating layers of bacteriorhodopsin, a light-sensitive protein.
On Earth, gravity-induced sedimentation and buoyancy effects hinder the uniformity of these layers, leading to increased material waste and limiting the production of viable implants. In the microgravity environment of space, these forces are absent, resulting in measurably different outcomes.
Through nine investigations conducted with commercial provider Space Tango, LambdaVision has refined a compact, automated system within CubeLab hardware. Each mission has allowed for the testing of fault detection, process repeatability, and quality-control documentation necessary for regulatory approval.
The consistent payoff has been that microgravity-produced retinas outperform Earth-made versions across all measured metrics, including layer uniformity, optical clarity, reproducibility, material efficiency, and long-term biocompatibility. This progress is significant as the implant targets age-related macular degeneration and retinitis pigmentosa, conditions affecting over 200 million people globally with no current cure.
A tenth ISS mission is planned for late 2026, focusing on increasing production volume, and the company has also secured capacity on the future Starlab commercial space station. LambdaVision's CEO, Nicole Wagner, stated that their flight projects on the ISS have significantly de-risked the demonstration of space-based manufacturing value.
This development highlights the critical role of microgravity in advanced biomanufacturing, particularly for complex layered structures like artificial retinas. By overcoming Earth-bound gravitational limitations, space-based additive manufacturing offers a pathway to produce higher-quality, more efficient medical devices, potentially revolutionizing treatments for degenerative diseases and pushing the boundaries of in-space production capabilities.
Edited by the news editor with AI from the original report — please refer to the original source.